Susquehanna International Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,600
Closed -$504K 12727
2024
Q1
$504K Buy
+7,600
New +$469K ﹤0.01% 8501
2022
Q3
Sell
-10,500
Closed -$478K 13731
2022
Q2
$478K Buy
+10,500
New +$470K ﹤0.01% 8375
2021
Q4
Sell
-4,900
Closed -$260K 13548
2021
Q3
$260K Buy
+4,900
New +$276K ﹤0.01% 10925

Other funds holding LMAT

Susquehanna International Group's LMAT Position: Q1 2026 in Review

Susquehanna International Group increased its LeMaitre Vascular (LMAT) stake by 261% in Q1 2026, buying an estimated $668K and bringing the position to 9,694 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #7749.

Susquehanna International Group first reported a position in LMAT in Q4 2016 and has held it in 15 quarters since. The position peaked at $2.17M in Q2 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Susquehanna International Group held 9,694 shares of LeMaitre Vascular worth $1.06M as of Q1 2026.
  • Susquehanna International Group bought 7,006 LeMaitre Vascular shares in Q1 2026, an estimated $668K.
  • LeMaitre Vascular made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7749 holding.
  • Susquehanna International Group first reported a position in LeMaitre Vascular in Q4 2016 and has held it in 15 quarters since.
  • Susquehanna International Group's LeMaitre Vascular position peaked at $2.17M in Q2 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.